Baltics

Lumoral: New Advances in the Scientific Research of Antibacterial Lumoral Treatment

Lumoral: New Advances in the Scientific Research of Antibacterial Lumoral Treatment

The Finnish oral health innovation, Lumoral, has sparked significant interest in the academic community, with several new studies launching in recent months. Mikko Kylmänen, Research Manager at Koite Health Oy, provides updates on Lumoral's latest clinical research.

Currently, there are 11 ongoing clinical studies across Finland, Sweden, Estonia, and Lithuania investigating the Lumoral method. Five of these are funded by Koite Health Ltd, while the rest are conducted by independent academic research teams. The studies cover topics such as periodontitis, peri-implantitis, orthodontics, oral lichen planus, and the prevention of oral diseases in youth.

In 2024, two new academic research teams will start their Lumoral studies. One study will examine the impact of improved oral hygiene on managing and preventing periodontitis in patients with diabetes. Another study will focus on enhancing oral hygiene for elderly individuals living at home or receiving home care.

In Italy, two research groups are advancing their Lumoral studies: The University of Turin is investigating the prevention of oral mucositis symptoms caused by radiation therapy, and Sapienza University in Rome is studying methods to alleviate early symptoms of peri-implantitis. Additionally, Saveetha Dental College and Hospitals in Chennai, India, is planning to start a Lumoral study in 2024 focused on treating oral mucositis related to cancer therapies.

Research on oral mucositis is particularly significant, as no existing medication has successfully prevented its development. Mucositis, an inflammation of the oral mucosa associated with cancer treatments such as radiation and chemotherapy, causes severe pain, redness, and swelling, which can negatively impact the success of cancer treatment. Recent findings suggest that light-activated antibacterial therapy may be an effective way to manage this condition.

Recent Lumoral Studies Initiated in Early 2024:

  1. HEALTHIER (Sweden): This study evaluates Lumoral's effectiveness in treating peri-implantitis and is conducted at the private Södertandläkarna clinic in Stockholm, Sweden, with 80 participants.
  2. LumOsteo: This research examines Lumoral's role in preventing complications related to implant placement. It is being conducted at the Hammaslääkärit Eteläranta 10 clinic in Helsinki, Finland, with 40 participants.
  3. Tartu University Plaque Study (Estonia): This crossover study compares two different oral hygiene methods and their effects on oral health. It is taking place at Tartu University in Estonia, where participants will alternate between using Lumoral and not using it to provide comparative results.

The HEALTHIER and LumOsteo studies are in their early stages, and precise timelines for results depend on factors such as patient recruitment. However, results from the Tartu plaque study are expected by the end of the year.

Summary of Previous Research Findings:

  • Pilot Study on Peri-Implantitis (2022): Showed promising results in treating implant-related inflammations with Lumoral, including significant reductions in plaque and gum bleeding without side effects.
  • Case Report on Periodontitis (2022): Demonstrated that Lumoral's antibacterial light treatment effectively eliminated harmful oral bacteria and improved severe periodontal disease outcomes.
  • Clinical Randomized Study on Periodontitis (2022): Indicated significant improvements in periodontitis treatment outcomes when Lumoral was added to daily care.
  • Clinical Randomized Study on Peri-Implantitis (2022): Observed reduced plaque, bleeding, and gum pocket sizes in Lumoral users compared to controls.
  • Randomized Study on Oral Hygiene in Elderly Care (2023): Found that light-activated Lumoral treatment improved oral health and moisture in elderly individuals residing in 24-hour care facilities.
  • Plaque Study in Healthy Adults (2023): Revealed that using Lumoral twice a week significantly reduced biofilm compared to a control group.

Innovation in Focus:

The ongoing and completed studies highlight Lumoral's versatile applications in improving oral health across various demographics and conditions. Mikko Kylmänen emphasizes that Lumoral's research opens new opportunities in oral care development. The company is proud to advance health and well-being through innovative solutions and looks forward to potential future applications of Lumoral.

For more information on Lumoral's research and effects, visit www.lumoralpro.com.

 

Reading next

HealthHub Pharma to Distribute Lumoral in Poland's Growing Preventive Dental Market
Lumoral to be Showcased at at the Scandinavian Society of Periodontology Conference in Visby, Sweden

Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.